The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis

The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis
复制标题

膜性肾病的遗传结构及其改善非侵入性诊断的潜力

DOI:
10.1038/s41467-020-15383-w
复制
发表时间:
2020-03-30
影响因子:
16.6
通讯作者:
Kiryluk, Krzysztof
Kiryluk, Krzysztof
中科院分区:
综合性期刊1区
文献类型:
--
作者:
Xie, Jingyuan;Liu, Lili;Kiryluk, Krzysztof

文献摘要

被引文献

相似文献

膜性肾病(MN)是一种罕见的由自身免疫导致肾衰竭的病因。在此,我们报告一项针对原发性膜性肾病的全基因组关联研究(GWAS),研究对象包括3782例东亚和欧洲血统的患者以及9038例对照。我们发现了两个此前未报道过的基因座,即NFKB1(rs230540,优势比 = 1.25,P = 3.4×10⁻¹²)和IRF4(rs9405192,优势比 = 1.29,P = 1.4×10⁻¹⁴),对PLA2R1基因座进行了精细定位(rs17831251,优势比 = 2.25,P = 4.7×10⁻¹⁰³),并报告了三个经典HLA等位基因的种族特异性效应:东亚人中的DRB1*1501(优势比 = 3.81,P = 2.0×10⁻⁴⁹)、欧洲人中的DQA1*0501(优势比 = 2.88,P = 5.7×10⁻⁹³),以及两个种族中的DRB1*0301(优势比分别为3.50,P = 9.2×10⁻²³和优势比 = 3.39,P = 5.2×10⁻⁸²)。GWAS基因座可解释东亚人32%的疾病风险和欧洲人25%的疾病风险,并且在验证队列中,对于血清抗PLA2R ELISA诊断测试抗体呈阴性的病例,能够正确重新分类20% - 37%。我们的研究结果凸显了膜性肾病不同寻常的遗传结构,四个基因座及其相互作用几乎占了疾病风险的三分之一。
Membranous Nephropathy (MN) is a rare autoimmune cause of kidney failure. Here we report a genome-wide association study (GWAS) for primary MN in 3,782 cases and 9,038 controls of East Asian and European ancestries. We discover two previously unreported loci, NFKB1 (rs230540, OR = 1.25, P = 3.4 x 10(-12)) and IRF4 (rs9405192, OR = 1.29, P = 1.4 x 10(-14)), fine-map the PLA2R1 locus (rs17831251, OR = 2.25, P = 4.7 x 10(-103)) and report ancestry-specific effects of three classical HLA alleles: DRB1*1501 in East Asians (OR = 3.81, P = 2.0 x 10(-49)), DQA1*0501 in Europeans (OR = 2.88, P = 5.7 x 10(-93)), and DRB1*0301 in both ethnicities (OR = 3.50, P = 9.2 x 10(-23) and OR = 3.39, P = 5.2 x 10(-82), respectively). GWAS loci explain 32% of disease risk in East Asians and 25% in Europeans, and correctly re-classify 20-37% of the cases in validation cohorts that are antibody-negative by the serum anti-PLA2R ELISA diagnostic test. Our findings highlight an unusual genetic architecture of MN, with four loci and their interactions accounting for nearly one-third of the disease risk.